2026 Global: Cell Isolation/Cell Separation Market-Competitive Review (2032) report
Description
The 2026 Global: Cell Isolation/Cell Separation Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell isolation/cell separation market by geography and historical trend. The scope of the report extends to sizing of the cell isolation/cell separation market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific, Danaher Corporation (including Beckman Coulter), Merck KGaA (MilliporeSigma), Becton, Dickinson and Company (BD Biosciences), Miltenyi Biotec, STEMCELL Technologies, Terumo Corporation (Terumo BCT), Bio‑Rad Laboratories, Agilent Technologies, and 10x Genomics are among the leading companies shaping the cell isolation and cell separation market. Thermo Fisher Scientific supplies a broad portfolio spanning flow cytometers, magnetic bead kits, microfluidic chips and reagents that support academic, clinical and industrial workflows and benefit from large global distribution and integrated informatics. Danaher Corporation operates through well‑known subsidiaries such as Beckman Coulter and Pall, offering centrifugation, flow cytometry, filtration and automated platforms that emphasize high throughput, instrument‑software integration and service networks for translational and manufacturing applications. Merck KGaA, via its MilliporeSigma brand, delivers filtration, density media, beads and consumables widely used in preparative separations and cell therapy manufacturing, leveraging regulatory and GMP capabilities for clinical‑grade workflows. Becton, Dickinson and Company (BD Biosciences) focuses on fluorescence‑based cytometry and sorting systems, reagents and automation tailored to immune profiling and clinical trial use, advancing spectral cytometry and clinically validated instruments. Miltenyi Biotec is recognized for pioneering magnetic‑activated cell sorting (MACS) and providing end‑to‑end solutions from research to GMP‑compatible kits for cell therapy, notable for high purity, scalability and single‑cell integration.
STEMCELL Technologies specializes in cell type‑specific reagents, isolation kits and culture media popular in stem cell and regenerative medicine research, with growing emphasis on GMP alignment and rare cell workflows. Terumo Corporation, through Terumo BCT, targets apheresis, blood processing and cell processing systems that serve cell therapy manufacturing and clinical collection needs, positioning itself in translational and clinical supply chains. Bio‑Rad Laboratories supplies reagents, low‑to‑mid throughput instruments and density gradient media favored by academic and smaller translational labs, maintaining a presence in assay development and CAR‑T supporting products. Agilent Technologies contributes instrumentation and analytical platforms, including microfluidics and single‑cell analytics, that integrate metabolic and functional assays with separation approaches to support drug discovery and translational research. 10x Genomics provides microfluidics‑based single‑cell partitioning and genomic profiling platforms that, while focused on single‑cell analysis, significantly influence upstream cell isolation requirements and workflows for high‑resolution cellular characterization.
Collectively these companies drive innovation across magnetic, fluorescence, centrifugation, filtration and microfluidic technologies, and they compete on breadth of consumables, automation, GMP readiness and informatics integration to serve research, clinical development and cell therapy manufacturing markets.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell isolation/cell separation market by geography and historical trend. The scope of the report extends to sizing of the cell isolation/cell separation market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific, Danaher Corporation (including Beckman Coulter), Merck KGaA (MilliporeSigma), Becton, Dickinson and Company (BD Biosciences), Miltenyi Biotec, STEMCELL Technologies, Terumo Corporation (Terumo BCT), Bio‑Rad Laboratories, Agilent Technologies, and 10x Genomics are among the leading companies shaping the cell isolation and cell separation market. Thermo Fisher Scientific supplies a broad portfolio spanning flow cytometers, magnetic bead kits, microfluidic chips and reagents that support academic, clinical and industrial workflows and benefit from large global distribution and integrated informatics. Danaher Corporation operates through well‑known subsidiaries such as Beckman Coulter and Pall, offering centrifugation, flow cytometry, filtration and automated platforms that emphasize high throughput, instrument‑software integration and service networks for translational and manufacturing applications. Merck KGaA, via its MilliporeSigma brand, delivers filtration, density media, beads and consumables widely used in preparative separations and cell therapy manufacturing, leveraging regulatory and GMP capabilities for clinical‑grade workflows. Becton, Dickinson and Company (BD Biosciences) focuses on fluorescence‑based cytometry and sorting systems, reagents and automation tailored to immune profiling and clinical trial use, advancing spectral cytometry and clinically validated instruments. Miltenyi Biotec is recognized for pioneering magnetic‑activated cell sorting (MACS) and providing end‑to‑end solutions from research to GMP‑compatible kits for cell therapy, notable for high purity, scalability and single‑cell integration.
STEMCELL Technologies specializes in cell type‑specific reagents, isolation kits and culture media popular in stem cell and regenerative medicine research, with growing emphasis on GMP alignment and rare cell workflows. Terumo Corporation, through Terumo BCT, targets apheresis, blood processing and cell processing systems that serve cell therapy manufacturing and clinical collection needs, positioning itself in translational and clinical supply chains. Bio‑Rad Laboratories supplies reagents, low‑to‑mid throughput instruments and density gradient media favored by academic and smaller translational labs, maintaining a presence in assay development and CAR‑T supporting products. Agilent Technologies contributes instrumentation and analytical platforms, including microfluidics and single‑cell analytics, that integrate metabolic and functional assays with separation approaches to support drug discovery and translational research. 10x Genomics provides microfluidics‑based single‑cell partitioning and genomic profiling platforms that, while focused on single‑cell analysis, significantly influence upstream cell isolation requirements and workflows for high‑resolution cellular characterization.
Collectively these companies drive innovation across magnetic, fluorescence, centrifugation, filtration and microfluidic technologies, and they compete on breadth of consumables, automation, GMP readiness and informatics integration to serve research, clinical development and cell therapy manufacturing markets.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
